glp-1 patches vs injections patch injection GLP-1 vs GLP-1 Injections: Understanding the Evidence GLP-1 Patches Vs GLP-1 Injections:

10.1053/j.gastro.2011.07.032 11

Obesity For weight loss, healthcare professionals may prescribe GLP-1 agonists for people with an initial BMI of 30 or higher or people who have a BMI of 27 or higher and at least one weight-related health condition, such as: type 2 diabetes prediabetes high blood pressure high cholesterol heart disease nonalcoholic fatty liver disease obstructive sleep apnea polycystic ovary syndrome Typically, healthcare professionals only prescribe these medications after someone has tried other weight loss methods, such as diet and exercise, without success

Proprietary lifestyle change curriculum: The curriculum includes evidence-based strategies that address hormonal, microbiome, and behavioral impacts on weight and metabolic health

Menopause typically triggers a 510 pound weight gain per decade in women over 50, driven by declining estrogen and slowed metabolism